Clinical Trial Update: A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen [NA]

View source ↗

Summary

A pilot trial evaluated switching from a boosted protease inhibitor regimen to raltegravir versus an NRTI backbone in HIV infection, with results posted in 2014…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• NRTI backbone (nucleoside reverse transcriptase inhibitors backbone)
• Raltegravir (raltegravir)

Snippet

Sponsor: University of South Florida | Conditions: Virus Diseases, HIV | NA | Status: COMPLETED | Results posted: 2014-07-22